Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Exchange Rate Effect (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Exchange Rate Effect for 7 consecutive years, with -$4000.0 as the latest value for Q1 2019.

  • Quarterly Exchange Rate Effect fell 110.26% to -$4000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was -$4000.0 through Dec 2019, down 125.0% year-over-year, with the annual reading at -$4000.0 for FY2019, 125.0% down from the prior year.
  • Exchange Rate Effect for Q1 2019 was -$4000.0 at Plus Therapeutics, down from $26000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $85000.0 in Q1 2016, with the low at -$58000.0 in Q4 2016.
  • Average Exchange Rate Effect over 5 years is $7000.0, with a median of $1000.0 recorded in 2016.
  • The sharpest move saw Exchange Rate Effect tumbled 3000.0% in 2015, then surged 466.67% in 2016.
  • Over 5 years, Exchange Rate Effect stood at $14000.0 in 2015, then tumbled by 514.29% to -$58000.0 in 2016, then surged by 96.55% to -$2000.0 in 2017, then soared by 1400.0% to $26000.0 in 2018, then crashed by 115.38% to -$4000.0 in 2019.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$4000.0, $26000.0, and -$22000.0 for Q1 2019, Q4 2018, and Q3 2018 respectively.